Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC

NCT00484016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2013-08-13

No results posted yet for this study

Summary

There are limited numbers of retrospective studies showing the effectiveness of adjuvant chemotherapy over observation in resected lung cancers.

Conditions

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Ramaswamy Govindan, M.D. · Washington University School of Medicine

Eligibility

Min Age
18 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2007-04-30
Completion
2007-04-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00484016 on ClinicalTrials.gov